[Central mechanism of the action of 17-alpha-hydroxy-progesterone capronate in the treatment of endometrial cancer].
D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use*; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000188:drug therapy*
D006908:Hydroxyprogesterones
O tsentral'nom mekhanizme deĭstviia 17-alpha-oksiprogesterona kapronata pri lechenii raka endometriia.